HIV&AIDS Theme A - Late Breaker Session (starts 9am)
Tracks
2
| Tuesday, November 7, 2017 |
| 8:45 AM - 10:30 AM |
| Sutherland Theatrette |
Speaker
Dr Lucette Cysique
Senior Research Fellow
Unsw Australia / NeuRA
A/Prof Patricia Price
Principal Research Fellow
Curtin university
Is HIV-Neuropathy The Same In Patients Treated Without Stavudine?
9:15 AM - 9:45 AMBiography
Patricia heads a team of clinicians and scientists in Australia, South Africa and Indonesia investigating the pathogenesis of sensory neuropathy in HIV patients. Neuropathy has changed since the withdrawal of stavudine - but not disappeared. We have new demographic, clinical and genetic data and insights into the underlying pathology.
Professor Damian Purcell
Professor of Virology and Theme Leader for Viral Infectious Diseases
Uni Melbourne, Doherty Institute
New HIV latency reversing agents that target novel gene expression pathways
9:45 AM - 10:00 AMBiography
Dr. Damian Purcell is a Professor in Virology and head of the molecular virology laboratory in the Department of Microbiology and Immunology at the University of Melbourne. He is Viral Infectious Diseases theme leader and GVN co-director at the Peter Doherty Institute, and on the executive committee of AVS, and ACH2. His research is in HIV and HTLV: gene expression, preventive vaccines, and antiviral and curative therapeutics.
A/Prof Ian Woolley
Deputy Director, Infectious Diseases
Monash Medical Centre
Phase 3 Randomized, Controlled, Clinical Trial of Bictegravir Coformulated With FTC/TAF in a Fixed-Dose Combination vs Dolutegravir + FTC/TAF in Treatment-Naïve HIV-1–Positive Adults: Week 48 Results
10:00 AM - 10:15 AMBiography
Dr Ian Woolley is Deputy Director of Infectious Diseases and Deputy Director of HIV Medicine at Monash Health as well as Adjunct A/Prof at Monash University
Ms Julie Newman
Senior Medical Manager
Gilead Sciences
A Phase 3 Randomized Controlled Clinical Trial Of Bictegravir In A Fixed-Dose Combination, B/F/Taf, Vs Abc/Dtg/3tc In Treatment-Naïve Adults At Week 48
10:15 AM - 10:30 AMBiography
Julie Newman is the Senior Medical Manager for HIV at Gilead Sciences ANZ.
